[Analysis of death rates in patients with tuberculosis and HIV infection]

Problemy Tuberkuleza I Boleznei Legkikh
|December 2, 2005
PubMed

Insights

Hospital mortality rates for tuberculosis patients saw a significant increase, rising from 4.2% in 2002 to 13.4% in 2003. Generalized tuberculosis and opportunistic infections were common, especially in immunocompromised individuals.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Hospital mortality rates for tuberculosis (TB) have been a concern.
  • Understanding trends in TB mortality is crucial for public health interventions.
  • Specific patient populations may be at higher risk.

Purpose of the Study:

  • To analyze trends in hospital mortality rates for tuberculosis patients.
  • To identify characteristics of patients with severe or generalized forms of tuberculosis.
  • To investigate the relationship between immunodeficiency and tuberculosis outcomes.

Main Methods:

  • Retrospective analysis of hospital mortality data for tuberculosis patients from 2001-2003.
  • Categorization of tuberculosis cases based on disease form (pulmonary, generalized) and patient history.
  • Assessment of patient immunodeficiency status.

Main Results:

  • Hospital mortality increased from 3.8% in 2001 to 4.2% in 2002, and sharply to 13.4% in 2003.
  • Patients with a long history of tuberculosis often presented with pulmonary-only disease.
  • Generalized tuberculosis occurred in over a third of cases, predominantly in immunocompromised patients.
  • Tuberculosis was frequently an opportunistic infection in patients with significant immunodeficiency.

Conclusions:

  • A significant surge in tuberculosis-related hospital mortality occurred in 2003.
  • Generalized tuberculosis and opportunistic infections pose a severe threat, particularly to immunocompromised individuals.
  • Effective management of tuberculosis requires addressing underlying immunodeficiency and disease dissemination.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: